Project Grant HT94252510062
Award Date
3/1/25
Completion Date
2/28/27
Dollars Obligated
$326K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Tacoma, WA 98402, USA
Similar Awards
This federal Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) provides $1,065,392.00 to The Geneva Foundation to conduct research on "LOCAL SLEEP IN THE WAKING BRAIN: A NOVEL TARGET FOR COGNITIVE FATIGUE". The project period runs from June 1, 2024 to May 31, 2028. As a non-profit research organization, The Geneva Foundation will perform foundational biomedical research investigating innovative treatments for...
The U.S. Department of the Army Medical Command awarded a $6,663,794 Project Grant on September 30, 2024 to The Geneva Foundation under the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant supports the "PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY" research initiative. The Geneva Foundation, a non-profit organization focused on medical research and services for the federal government, will be the prime awardee. The...
The Geneva Foundation was awarded a $1,597,740 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from June 2022 to June 2026 to develop new methods for accessing extracellular vesicle MDM2 DNA cargo as a potential liposarcoma biomarker. Through support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...
The Cooperative Agreement award, funded by the Uniformed Services University of Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750), provides $755,269.00 to The Geneva Foundation to characterize sleep neurophysiology after blast exposure. This research aims to address the missing link in comprehensive neurological blast assessments, which is critical for improving medical care and support for military personnel. The Geneva Foundation, a...
The Geneva Foundation will receive $910,559 under a Cooperative Agreement awarded by the Department of the Army Medical Command on August 15, 2022. The funding supports a research project titled "In Vivo Imaging of Lymphatic Circulation: Measurement of Brain Interstitial Fluid Flow During Wake and Sleep with Ultra-High Performance MRI." The project aims to investigate medical solutions for the battlefield by transforming health care through innovative and impactful research, as part of...
The Geneva Foundation was awarded a $1,054,546 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420). The three-year grant will support research into the role of U2AF1 mutations in myelodysplastic syndrome and their potential role as a noncanonical splicing factor in bone marrow failure. Through July 2025, the Geneva Foundation will investigate how these genetic mutations impact splicing and the development of...
This Cooperative Agreement award in the amount of $744,897.00 was provided by the Uniformed Services University of the Health Sciences under the Uniformed Services University Medical Research Projects program (CFDA 12.750). The award supports medical research, development, and clinical trials conducted by The Geneva Foundation, a 501(c)(3) non-profit organization based in Tacoma, Washington. The research will focus on advancing military medical capabilities and addressing critical healthcare...
This Project Grant award for $366,000.00, awarded on Sep 30, 2024 by the Defense Health Agency, supports research conducted by The Geneva Foundation to identify functional structural variants that influence therapy outcomes for human castration-resistant prostate cancer. The award is funded through the Military Medical Research and Development program (CFDA 12.420), which supports a broad range of biomedical research initiatives to improve health outcomes for military service members,...
The Geneva Foundation was awarded a $362,100 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program to conduct research toward the dual targeting of HER2 and androgen receptor in patients with high-risk, hormone-naive prostate cancer with curative intent. The two-year grant project period runs from June 1, 2022 to May 31, 2024. Through this funding, The Geneva Foundation will perform applied medical research investigating...
The Department of the Army Medical Command awarded a $384,001 Project Grant to Cold Spring Harbor Laboratory under the Military Medical Research and Development program (CFDA 12.420). The grant will fund research from March 1, 2022 to February 29, 2024 to investigate the neural circuit mechanisms of stress-induced insomnia and metabolic dysfunction. Through its support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform...